5
Views
1
CrossRef citations to date
0
Altmetric
Letter

HLA-B27-transgenic rats, amyloid deposits, and spondyloarthropathies

&
Pages 425-426 | Received 18 Feb 2008, Accepted 05 Mar 2008, Published online: 02 Jan 2014

References

  • Fukunishi S, Yoh K, Kamae S, Yoshiya S. Beta 2-microglobulin amyloid deposit in HLA-B27 transgenic rats. Mod Rheumatol. 2007;17:380–4.
  • Gejyo F, Yamada T, Odani S, Nakagawa Y, Arakawa M, Kuni-tomo T, et al. A new form of amyloid protein associated withb chronic hemodialysis was identified as beta 2-microglobulin. Biochem Biophys Res Commun. 1985;129: 701–6.
  • Cruickshank B. Pathology of ankylosing spondylitis. Bull Rheum Dis. 1960;10:211–4.
  • Lehtinen K. Mortality and causes of death in 398 patients admitted to hospital with ankylosing spondylitis. Ann Rheum Dis. 1993;52:174–6.
  • WTCCC TASC. A genome-wide scan of 14,000 non-synony-mous coding SNPs in 5,500 individuals: the Wellcome Trust Case Control Consortium. Nat Genet. 2007;39:1329–37.
  • Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2 m: an animal model of HLA-B27-associated human disorders. Cell. 1990;63: 1099–112.
  • Taurog JD, Maika SD, Satumtira N, Dorris ML, McLean IL, Yanagisawa H, et al. Inflammatory disease in HLA-B27 trans-genic rats. Immunol Rev. 1999;169:209–23.
  • Tran TM, Dorris ML, Satumtira N, Richardson JA, Hammer RE, Shang J, et al. Additional human beta2 m curbs HLA-B27 mis-folding and promotes arthritis and spondylitis without colitis in male HLA-B27 transgenic rats. Arthritis Rheum. 2006;54:1317–27.
  • Ziegler A, Loll B, Misselwitz R, Uchanska-Ziegler B. Implica-tions of structural and thermodynamic studies of HLA-B27 subtypes exhibiting differential association with ankylosing spondylitis. In: López-Larrea C, editor. Molecular mechanisms of spondyloarthropathies. Austin: Landes Bioscience; 2008 (in press).
  • Uchanska-Ziegler B, Ziegler A. Ankylosing spondylitis: a fign-deposition disease? Trends Immunol. 2003;24:73–6.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.